首页> 外文会议>Annual^Conference of The New^Zealand^Society^of^Animal^Production >Effects of maternalbromocriptine and melatonin treatments during early gestation on fetal lamb growth
【24h】

Effects of maternalbromocriptine and melatonin treatments during early gestation on fetal lamb growth

机译:母体溴隐亭和褪黑素治疗在胎儿羊羔生长早期妊娠中的影响

获取原文

摘要

Lower birth weights of autumn-born than of spring-born lambs may be due to a seasonal impairment of placental development, established by d84 of gestation, and perhaps mediated by high summer prolactin concentrations. This study attempted to determinewhether reducing circulating summer prolactin concentrations in ewes during early gestation, using bromocriptine and melatonin, would improve placental and fetal growth and birth weights of autumn-born lambs. Pregnant mixed-age Romney ewes were randomlyallocated to three treatment groups, balanced for age, live weight (LW) and source flocks, on dl5 after mating. Ewes in the Bromocriptine group (n=20, LW 58.3±6.7 kg) were injected with 50 mg ParlodePLA, the Melatonin group (n=20, LW 58.6±6.6 kg) eachreceived one 18-mg Regulin implant, while the Control group (n=21, LW 58.5±5.8 kg) was injected with saline solution (0.9% NaCl). At dl39 of gestation, ewes were randomly allocated to a 'Slaughter group' sacrificed at dl40-2 (n=30 LW 61.2±5.6 kg) anda 'Live-birth group' (n=31, LW 60.0±7.1 kg). Maternal plasma prolactin concentrations were significantly reduced by both bromocriptine (Control vs. Bromocriptine): 48.3±9.2 vs. 0.7±9.9 ng/ml (PO.001) at d20 of gestation, and 82.6±8.5 vs. 4.5±9.1 ng/ml (PO.001) at d40 of gestation, and melatonin treatments (Control vs. Melatonin): 82.6±8.5 vs. 18.4±9.5 ng/ml (PO.001) at d40 of gestation, and 16.8±3.7 vs. 2.9±4.2 ng/ml (PO.05) at d60 of gestation. Fetal plasma prolactin concentrations were not affected by treatments (Control vs. Bromocriptine vs. Melatonin): 32.4±18.3 vs. 32.4±19.1 vs. 59.8±16.4 ng/ml. At dl40 of gestation, there were no treatment effects (adjusted for sex and litter size) on fetal weight, crown-rump length, placental parameters, and maternal and fetal organ weights, except thymus reduced 20% (PO.05) by melatonin treatment. Birth weights and subsequent growth rates were similar among groups. Despite treatments reducing plasma prolactin concentrations there was no affect onplacental or fetal growth, indicating that high prolactin concentrations early in pregnancy are not responsible for low birth weight in ewes lambing in May.
机译:低出生体重秋天出生的比春天出生的羊羔可能是由于胎盘发育的季节性障碍,通过妊娠D84建立,也许夏季高浓度的催乳素介导的。本研究试图determinewhether减少妊娠早期母羊循环夏天催乳素浓度,使用溴隐亭和褪黑激素,将改善秋天出生的羔羊胎盘和胎儿的生长和出生体重。孕妇混龄罗姆尼母羊randomlyallocated到三个治疗组,年龄平衡,活重(LW)和源成群,在配种后DL5。的溴隐亭组母羊​​(n = 20的LW 58.3±6.7千克)与50mg ParlodePLA,所述褪黑激素组(n = 20,LW 58.6±6.6千克)注射eachreceived一个18毫克Regulin植入物,而对照组( N = 21,LW 58.5±5.8千克)用生理盐水溶液(0.9%NaCl)中注射。在妊娠的DL39,母羊被随机分配到在dl40-2(N = 30 LW 61.2±5.6千克)安达 '活产组'(N = 31,LW 60.0±7.1千克)牺牲了 '屠宰组'。母体血浆催乳素浓度由两个溴隐亭(控制与溴隐亭)中显著降低:在妊娠的D20 48.3±9.2与0.7±9.9纳克/毫升(PO.001),和82.6±8.5对4.5±9.1纳克/毫升(PO.001),在其怀孕的D40,和褪黑激素治疗(对照对褪黑素):82.6±8.5对比18.4±9.5纳克/毫升(PO.001),在其怀孕的D40,和16.8±3.7对2.9±4.2纳克/毫升(PO.05),在其怀孕的D60。胎儿血浆催乳素浓度并没有受到处理(对照对溴隐亭与褪黑激素):32.4±18.3对比32.4±19.1对比59.8±16.4毫微克/毫升。在妊娠的DL40,没有治疗效果(调整性别和产仔数)对胎儿重量,顶臀长,胎盘参数,和母体和胎儿器官重量,除胸腺褪黑素处理降低20%(PO.05) 。出生体重和随后的增长率分别为组相似。尽管治疗降低血浆催乳素浓度没有影响onplacental或胎儿生长,这表明高泌乳素浓度在怀孕早期不负责母羊五月产羔低出生体重。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号